Library - Page 6
Registered on ClinicalTrials
The effect of antioxidant therapy on some pathogenetic factors of primary open -angle glaucoma
Authors:
T.N. MALISHEVSKAYA1, Yu.E. FILIPPOVA2
1Federal State Budgetary Institution "Helmholtz National Medical Research Center for Eye Diseases" of the Ministry of Health of the Russian Federation, Moscow, Russia;
2State Autonomous Healthcare Institution of the Tyumen Region "Regional Ophthalmological Dispensary", Tyumen, Russia
Experience in the use of metabolic drugs in interventional cardiology
Authors:
A.A. Spassky, A.A. Mikhailov
Place of publication:
CARDIONEUS, 2016
The possibilities and results of the use of antioxidant therapy in ophthalmological practice
Authors:
A.B. MOVSISYAN1,2, Zh.G. OGANEZOVA2,3, E.A. EGOROV2
1Hospital for War Veterans No. 2 of the Moscow Health Department, Moscow, Russia;
2Pirogov Russian National Research Medical University, Moscow, Russia;
3Bochkov Medical Genetic Research Center, Moscow, Russia
The use of Mexidol in the treatment of primary open -angle glaucoma
Authors:
I.A. LOSKUTOV, O.M. ANDRYUKHINA, A.A. KOVRIZHKINA
Moscow Regional Research Clinical Institute. M.F. Vladimir
The experience of neuroprotective therapy of primary open -angle glaucoma based on the use of various forms of Mexidol
Authors:
E.S. LEONOVA1,2, S.V. POLYAKOV1,2, M.A. POZDNYAKOVA2, E.P. YARYGINA3, S.O. SEMISYNOV2
1.NGO "Road Clinical Hospital at Gorky Station of JSC "Russian Railways", Inter-Road Ophthalmology Center
2.State Budgetary Educational Institution of Higher Professional Education "Nizhny Novgorod State Medical Academy"
3.State Budgetary Healthcare Institution of the Nizhny Novgorod Region "City Hospital No. 35", City Glaucoma Center
The experience of neuroprotective therapy of primary open -angle glaucoma based on the use of various forms of Mexidol
Authors:
E.S. Leonova1, 2, S.V. Polyakov1, 2, M.A. Pozdnyakova2, E.P. Yarygin3, S.O. Semisov2
1 nose "Road Clinical Hospital at the Gorky station OJSC" Russian Railways ", the interdorrutal center of ophthalmology, 18 Lenin Ave., Nizhny Novgorod, Russian Federation, 603140;
2GBOU VPO Nizhny Novgorod State Medical Academy, pl. Minina and Pozharsky, 10/1, Nizhny Novgorod, Russian Federation, 603950;
3GBUZ but "City Hospital No. 35", City Glack Center, ul. Osharskaya, 15, Nizhny Novgorod, Russian Federation, 603005
Place of publication:
Bulletin of ophthalmology 6, 2015
Assessment of Mexidol's effectiveness in the complex treatment of glaucomone neuropathy
Authors:
A.N. BOLATBEKOVA, D.E. KOPBAEVA, A.I. ARINOVA, B.S. ABRAKHMANOVA
LLP "Center for Eye Microsurgery", Karaganda;
KGP "Regional Clinical Hospital", Karaganda;
Karaganda State Medical University, Karaganda
Our experience in the use of Mexidol in the complex treatment of patients with primary open -angle glaucoma
Authors:
E.A. AFONINA, M.A. LEVKO, L.V. CHEKUROVA, T.I. KOSACHEVA
SZGMU them. I.I. Mechnikov, St. Petersburg
Antioxidant drug in neuroprotective therapy for glaucoma
Authors:
E.A. EGOROV1, A.A. GVETADZE1, N.G. DAVYDOVA2
1Pirogov Russian National Research Medical University;
2Helmholtz Moscow Research Institute of Eye Diseases of the Russian Ministry of Health
The effectiveness of the use of 3-oxypyridine and amber acid derivatives in the complex treatment of primary open-angle glaucoma
Authors:
I.A. VOLCHEGORSKY1, E.V. ROUND1, O.V. SOLYANNIKOVA1, V.S. RYKUN1, M.S. SUMINA2, V.N. DMITRIENKO2, E.V. BERDNIKOVA1
1Department of Pharmacology (Head - Prof. I.A. Volchegorsky) and Department of Eye Diseases (Head - V.S. Rykun) State Budgetary Educational Institution of Higher Professional Education "Chelyabinsk State Medical Academy" of the Ministry of Health and Social Development of the Russian Federation
2Microsurgery Department (Head - V.N. Dmitrienko) State Medical Healthcare Institution "Chelyabinsk Regional Clinical Hospital", Medgorodok
The influence of a water -soluble antioxidant drug (Mexidol) on the sensitivity of the optic nerve and blood flow velocity in the arteries of the eyeball and orbit in patients with the primary open -angle glaucoma
Authors:
I.A. VOLCHEGORSKY1, E.V. ROUND1, O.V. SOLYANNIKOVA1, V.S. RYKUN1, E.V. BERDNIKOVA1, M.S. SUMINA2, V.N. DMITRIENKO2
1State Budgetary Educational Institution of Higher Professional Education "Chelyabinsk State Medical Academy" of the Ministry of Health and Social Development of the Russian Federation;
2State Medical and Public Health Institution "Chelyabinsk Regional Clinical Hospital"
Mexidol in the complex treatment of glaucoma
Author:
E.A. EGOROV, N.G. DAVYDOVA, I.A. ROMANENKO, N.D. NOVIKOVA
RNIMU named after N.I. Pirogov, GB of GB named after Helmholtz, Moscow
Mexidol in the complex therapy of stable angina pectoris
Authors:
G. I. NECHAYEVA1, S. D. KUROCHKINA2, A. D. TROTSENKO3, E. Yu. BULAKHOVA2
1Omsk State Medical Academy
2BUKOO City Clinical Hospital No. 4
3BUKOO Medical Center of the Ministry of Health of Omsk Region
International multicenteric randomized double-tied placebo-controlled study of evaluating the effectiveness and safety of sequential therapy of patients with chronic brain ischemia drugs Mexidol® and Mexidol® Forte 250 (study of memo): Subanalysis results in patients with arterial hypertension
V.V. ZAKHAROV1, O.D. OSTROUMOVA1,2, A.I. KOCHETKOV2, M.V. KLEPIKOVA2, A.I. FEDIN3
1Federal State Autonomous Educational Institution of Higher Education “I.M. Sechenov First Moscow State Medical University” of the Russian Ministry of Health (Sechenov University);
2Federal State Budgetary Educational Institution of Higher Professional Education “Russian Medical Academy of Continuous Professional Education” of the Russian Ministry of Health, Moscow;
3Federal State Autonomous Educational Institution of Higher Education “N.I. Pirogov Russian National Research Medical University” of the Russian Ministry of Health, Moscow
Place of publication:
THERAPY No. 1 (63) 2023
To the question of the evidence base of neuroprotective therapy: Focus on ethylmethylhydroxypyridine succinate
Authors:
A.I. KOCHETKOV, N.A. SHATALOVA, M.V. KLEPIKOVA, T.V. FILIPPOVA, O.D. OSTROUMOVA
Federal State Budgetary Educational Institution of Higher Professional Education “Russian Medical Academy of Continuous Professional Education” of the Ministry of Health of the Russian Federation, Moscow
The effectiveness of Mexidol in patients of different age groups with chronic brain ischemia with cognitive disorders (the results of subanalysis of the international multicenter randomized double blind placebo-controlled study of memes)
Zakharov V.V. 1*, Tkacheva O.N. 2*, 3*, Mkhitaryan E.A. 2*, 3*, Fedin A.I. 2*
1* I.M. Sechenov First Moscow State Medical University of the Russian Ministry of Healthcare
(Sechenov University), Moscow, Russia;
2* N.I. Pirogov Russian National Research Medical University of the Russian Ministry of Healthcare,
Moscow, Russia;
3* Russian Gerontology Research and Clinical Center of N.I. Pirogov Russian National Research
Medical University of the Russian Ministry of Healthcare, Moscow, Russia
Place of publication:
S.S. Korsakov Journal of Neurology and Psychiatry
2022, Vol. 122, No. 11, Issue 2, pp. 73–80
THE INFORMATION IS INTENDED FOR HEALTHCARE AND PHARMACEUTICAL PROFESSIONALS. THIS INFORMATION IS NOT INTENDED AS A SUBSTITUTE FOR MEDICAL ADVICE.
Source of photos and images Shutterstock.com